Liste de publications de Isabelle Demeestere

Participations à des congrès et colloques internationaux (171)

65. Devos, M., Grosbois, J., & Demeestere, I. (2018). PI3K/Akt/mTOR and Hippo signaling pathways interactions during in vitro mice ovarian follicles activation. Poster présenté à la conférence 3rd FRM (Foundation for Reproductive Medicine) Conference (November 2018: New York, United States of America).
66. Demeestere, I. (2018). Fertility preservation: The emerging evidence: Invited Speaker. Paper session presented at ASRM (American Society for Reproductive Medicine) Pre congress (07 Octobre 2018: Denver, USA).
67. Olympios, N., Lambertini, M., Calbrix, C., Saint-Ghislain, M., Fontanilles, M., Loeb, A., Leheurteur, M., Demeestere, I., Di Fiore, F., Perdrix, A., & Clatot, F. (2018). Impact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). Poster présenté à la conférence ESMO (19-23/10/2018: Munich, Germany).
68. Lambertini, M., Di Maio, M., Poggio, F., Pagani, O., Curigliano, G., Del Mastro, L., Paluch-Shimon, S., Loibl, S., Partridge, A. H., Azim, H. A., Peccatori, F. A., & Demeestere, I. (2018). Physicians’ knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey. Poster présenté à la conférence ESMO (19-23/10/2018: Munich, Germany).
69. Devos, M., Grosbois, J., & Demeestere, I. (2018). PI3K/Akt/mTOR and Hippo signaling pathways interactions during in vitro mice ovarian follicles activation. Poster présenté à la conférence 3rd Annual Symposium of the U-CRC (ULB-Cancer Research Center) (September 2018: Brussels, Belgium).
70. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. Abstract session presented at U-CRC (ULB-Cancer Research Center)(3: 28 septembre 2018: Bruxelles, Belgique)
71. Demeestere, I. (2018). Protection pharmacologique aux analogues de la GnRH pendant la chimiothérapie: fin du débat?: Invited Speaker. Paper session presented at Journées de la Fédération Française d'Etude de la Reproduction (23: 2018-09-13: Lyon, France).
72. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. Paper session presented at Congress Bonding Embryologists to Fertility specialists to assist Nature in Overcoming Infertility (2nd: Thessaloniki, Greece).
73. Alexandri, C., Stamatopoulos, B., Rothé, F., & Demeestere, I. (2018). Identification and efficiency assessment of potential miRNAs targets for developing new pharmacological drugs against chemotherapy induced ovarian damage using mice model. 34th Annual Meeting of the European Society of Human Reproduction and Embryology: + Short Talk Presentation. Poster présenté à la conférence ESHRE (34th: 01-04/07/2018: Barcelona, Spain).
74. Demeestere, I. (2018). Update on outcomes of reimplanted ovarian tissue : Invited speaker. Paper session presented at ESHRE campus : The future fertility of women cancer survivors (03-05/05/2018: Tbilisi, Geogia).
75. Demeestere, I. (2018). Markers of malignant cells in the ovarian tissue: Invited speaker. Paper session presented at ESHRE campus : The future fertility of women cancer survivors (03-05/05/2018: Tbilisi, Georgia).
76. Demeestere, I. (2018). Fertility preservation technique in young patients: to whom and how? Invited speaker. Paper session presented at CURRENT MANAGEMENT OF BREAST CANCER : Workshop of Medical Oncologists (18/04/2018: Bordet Institute, Brussels).

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Suivant >>